Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001471518-21-000002

Director sold 47,881 shares at $35.04 ($1,677,741)

  • Director acquired 60,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Phanstiel S. Louise · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-05 Exercise or conversion : show line 1 in the form +30,000 $25.39 $761,700 109,527 D
2021-08-05 Sale : show line 2 in the form −47,881 $35.04 $1,677,741 61,646 D
2021-08-05 Exercise or conversion : show line 3 in the form +30,000 $21.29 $638,700 91,646 D
Open-market sales · 47,881 sh · avg $35.04 · $1,677,741

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-08-05 Exercise or conversion : show line 4 in the form Non-Qualified Stock Option (right to buy) −30,000 0 D
2021-08-05 Exercise or conversion : show line 5 in the form Non-Qualified Stock Option (right to buy) −30,000 0 D
Loading xslF345X03/edgardoc.xml…